Cell C says it monitors the activity of wireless application service providers (WASPs) on its network and takes decisive action if they fail to meet compliance or customer experience standards.

While many investors have turned their backs on Cell C, financial investment firm Allan Gray has doubled down in its backing of the struggling mobile network operator. Cell C’s listing on the ...

Soley Therapeutics has secured $200 million in series C funds, which the artificial-intelligence-enabled biotech plans to use to take its lead acute myeloid leukemia (AML) asset into the clinic. The ...